Jushi Holdings
Publicly traded US cannabis operator with retail and cultivation in multiple state markets.
Jushi is a mid-sized, publicly traded cannabis company—not a household name. Its strength is retail footprint in limited-license states like Pennsylvania and Virginia. Claims about 'premium genetics' or superior flower quality are marketing; independent lab comparisons across MSO brands barely exist. Check state regulators' license lists and product COAs, not brand websites. Cross-state consistency is impossible under federal law.
What it is
Jushi Holdings Inc. is a publicly traded, vertically integrated cannabis company headquartered in Boca Raton, Florida [1]. It was founded in 2018 by Jim Cacioppo, Erich Mauff, and Jon Barack, and lists on the Canadian Securities Exchange (CSE) under ticker JUSH and over-the-counter in the US as JUSHF [1].
The company operates cultivation, processing, and retail across multiple US state markets. As of 2024 investor filings, Jushi's operating footprint included Pennsylvania, Virginia, Illinois, Ohio, Massachusetts, and Nevada, with historical operations in California [1][2]. State-level operations change frequently—always consult current SEC or SEDAR+ filings before relying on this list.
Ownership and corporate structure
Jushi is not owned by a larger parent company; it is itself a publicly listed holding company [1]. Jim Cacioppo serves as Chairman and CEO and is among the largest shareholders.
Operating subsidiaries hold the state-level cannabis licenses—a standard structure forced by federal prohibition. Because cannabis remains a Schedule I controlled substance, no US cannabis operator can legally consolidate licenses across state lines, so each state operation functions as a legally independent entity Strong evidence[4]. This structure is uniform across all large US MSOs.
Because Jushi trades on the Canadian Securities Exchange, it files continuous disclosure documents—annual information forms (AIF), management discussion & analysis (MD&A), and audited financial statements—on SEDAR+ [3]. These filings are the authoritative source for current subsidiaries, license counts, financial performance, and material risks. Marketing copy, press releases, and investor deck summaries are not reliable; read the official filings directly.
Market focus and consumer brands
Jushi's core strategy emphasizes retail operations under the Beyond Hello banner, with store locations concentrated in limited-license states like Pennsylvania and Virginia where dispensary permits are scarce and economically valuable [1][2].
The company also cultivates and manufactures cannabis products under its own consumer brands for both medical and adult-use markets where legal:
- The Bank — flower and pre-rolls, positioned around genetics sourced from The Bank Genetics breeder catalog
- Seche — vape and concentrate product line
- Nira — wellness-positioned products including tinctures and topicals
- Tasteology — edibles line in select markets
Important caveat: Brand names have no consistency across state lines. Federal prohibition means cannabis cannot legally cross state borders. A "Seche" vape cartridge sold in Pennsylvania is manufactured, tested, and sourced separately from a "Seche" product in Nevada—they are not the same product despite sharing a name Strong evidence[4]. Marketing that emphasizes genetics or cultivation standards for a particular brand applies only to the specific state where that product was made.
Reputation, awards, and financial standing
Jushi is a mid-tier US cannabis operator by revenue, smaller than major MSOs such as Green Thumb Industries (GTI), Curaleaf, Trulieve, and Verano Holdings [2].
Awards and quality claims: The Bank flower line is promoted on the basis of genetics from an established breeder catalog. However, published, independent, blinded quality comparisons of flower across MSO brands do not exist in the scientific literature No data. Cannabis competitions and cups—often used to market "award-winning" strains—are not peer-reviewed and do not provide reliable quality assurance. Treat such claims as marketing material.
Financial condition: Jushi, like most US MSOs, has reported recurring net losses and significant debt service as of its most recent filings [2]. This reflects industry-wide pressures including IRC Section 280E tax treatment (which prevents cannabis businesses from deducting ordinary operating expenses), price compression from oversupply in many markets, and limited access to traditional banking due to federal prohibition [2]. Investors should read Jushi's most recent MD&A directly rather than rely on promotional statements.
Regulatory context and controversies
There is no widely reported, independently verified scandal unique to Jushi as of this profile's last check. The company has undergone layoffs, market exits, and operational restructurings typical of the post-2021 cannabis downturn [2]. Such moves reflect broader industry contraction rather than company-specific misconduct.
As with all US cannabis operators, Jushi operates under fundamental constraints:
- Cannabis remains classified as a Schedule I controlled substance under federal law [4]
- State licensing, product testing standards, and permitted product categories vary significantly by jurisdiction
- Recalls for pesticide residues, microbial contaminants, or labeling violations do occur. Consult your state regulator's recall database for product-specific issues
- Cross-state regulatory inconsistency means a compliant product in one state may be prohibited in another
Availability and legitimate channels
Jushi cannabis products containing THC are sold only through state-licensed dispensaries in states where Jushi holds active licenses Strong evidence[4]. No US cannabis operator—including Jushi—legally ships cannabis products across state lines Strong evidence[4].
If you encounter a website claiming to mail-order Jushi-branded THC flower, vapes, or edibles to a state outside Jushi's licensed footprint, that channel is not legitimate. The company does not operate mail-order services for controlled cannabis products.
Note: Hemp-derived CBD or delta-8 products sold under similar brand names are a separate category and may not be affiliated with Jushi's state-licensed cannabis operations. Verify the source and hemp vs. cannabis designation on any product label.
How to verify claims before relying on them
Before relying on any claim about a Jushi product or the company itself:
- Check the Certificate of Analysis (COA). Cannabinoid percentages, terpene profiles, and contaminant test results should appear on a specific, batch-dated COA—not a generic strain page. The testing lab should be accredited by your state regulator.
- Verify the license. Check your state's cannabis regulatory body (e.g., Pennsylvania Department of Health, Virginia Cannabis Control Authority) for Jushi-affiliated licensees and dispensaries. State regulator lists are the only authoritative source.
- Read SEDAR+ filings directly [3]. Current ownership, subsidiary structure, license count, and material business risks are disclosed in quarterly and annual filings, not in press releases or investor decks.
- Treat marketing language with skepticism. Terms like 'craft,' 'premium,' 'small-batch,' 'award-winning,' and 'estate-grown' are not regulated in cannabis and serve as marketing rather than meaningful distinctions. If a claim sounds compelling, ask for specific, verifiable cultivation or testing data—not a brand story.
- Do not assume cross-state brand consistency. Federal prohibition means Jushi's Pennsylvania operation and Nevada operation are legally separate entities. Brand names may be shared, but formulations, sourcing, and quality standards are not.
Sources
- Reported Jushi Holdings Inc. company profile and leadership information. Crunchbase.
- Reported MJBizDaily coverage of Jushi Holdings, including market footprint, financial reporting, and restructuring news (2022–2024).
- Government Canadian Securities Administrators. SEDAR+ public filings database. Search 'Jushi Holdings' for continuous disclosure documents.
- Government US Drug Enforcement Administration. Orange Book: Drug Scheduling Information. Marijuana / Cannabis listed as Schedule I under the Controlled Substances Act.
How this page was made
Generation history
Drafted with AI assistance and checked by a separate automated fact-check pass. Not every article has been read by a person. See how articles are made.
Related
- Acreage Holdings — US cannabis operator with conditional Canopy ownership and The Botanist retail brand.
- Ascend Wellness Holdings — US multi-state operator with retail and wholesale presence across East Coast and Midwest m...
- Green Thumb Industries (GTI) — US multi-state cannabis operator and retailer founded in 2014, publicly traded, with culti...
- Verano Holdings — Publicly traded US cannabis multi-state operator with retail and production across license...